BGI to Add 11 Illumina Analyzers, 3 454 GS FLX; Plans Service in Europe
The Beijing Genomics Institute is expanding its sequencing capacity by adding 14 next-generation sequencers, the institute said last week.
BGI said it has ordered 11 new Illumina Genome Analyzers and three 454 Genome Sequencer FLX instruments. The Institute already owns six Illumina sequencers, as well as 26 ABI 3730xl sequencers and 107 GE Healthcare MegaBace 1000 sequencers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Sponsored by

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.